Liveyon

Liveyon made $21.6 million says DOJ; leader gets 3 years prison for stem cell activities

Liveyon

Back in late August, Liveyon leader John Kosolcharoen pleaded to federal charges on stem cells. What was Liveyon? Liveyon was a splashy umbilical cord stem cell supplier company. I don’t know if the company is still active now. One of its core products ended up sending dozens of people to the hospital due to contamination […]

Liveyon made $21.6 million says DOJ; leader gets 3 years prison for stem cell activities Read More »

Feds want $3M, prison for Liveyon founder in old fraud case

John Kosolcharoen, Liveyon

Before starting the umbilical cord cell supplier and marketing firm Liveyon, John Kosolcharoen was involved in some alleged health care fraud. The feds brought a case against him related to prescription drugs. Older case coming to a head As Liveyon was having its misadventures in the stem cell clinic sphere, the status of that past

Feds want $3M, prison for Liveyon founder in old fraud case Read More »

Liveyon is back (again) with unproven exosome product

Liveyon

Remember our old friends Liveyon? Their leader John Kosolcharoen? Liveyon’s continuing metamorphosis This biologics supply firm has gone through several stages of corporate metamorphosis as a supplier of biologics including at first a purported living umbilical cord stem cell product. That stem cell thrust ultimately landed a dozen or more people in the hospital as

Liveyon is back (again) with unproven exosome product Read More »

More Liveyon links to exosome Awakening film include potential relative

Awakening-film-marketing-screenshot

A new film-commercial entitled Awakening pitches unproven exosomes and has already been possibly tied to the troubled stem cell supplier firm Liveyon, but now it seems that the links go far deeper including a possible relative of Liveyon leader John Kosolcharoen. Even so, Kosolcharoen (pictured with another Liveyon leader Alan Gaveck below in a web

More Liveyon links to exosome Awakening film include potential relative Read More »

Mystery of wild sci-fi film ad for unproven exosomes: Liveyon?

awakening-exosome-film-ad

What’s Liveyon up to these days? A new, somewhat mysterious short film that serves as an advertisement for unproven exosomes has some of us scratching our heads. It seems to point to Liveyon. Can you guys as readers of The Niche help solve the puzzle of who’s behind this wild “cinematic commercial” and what the

Mystery of wild sci-fi film ad for unproven exosomes: Liveyon? Read More »

Why did clinic supplier Liveyon halt sales but others kept going despite FDA?

Liveyon-reincarnated

Umbilical “stem cell” supplier Liveyon has suspended sales of its products according to the WaPo after a harsh FDA warning letter. While not fully shutting off the tap to the perinatal stem cell clinic universe, as other suppliers including in Utah seem to be continuing, this Liveyon voluntary hold will equal a major reduction in

Why did clinic supplier Liveyon halt sales but others kept going despite FDA? Read More »

FDA spike: clinic supplier Liveyon warning letter & 483s; notice on exosome harms

Roya-Panah-Kosolcharoen

Friday and Saturday showed a burst in FDA activity related to unproven stem cells and regenerative products including a warning letter to the unproven perinatal “stem cell” provider Liveyon. This was an unusual 48-hour period and a very good one for those who believe in science-based regenerative medicine but in my view a bad day

FDA spike: clinic supplier Liveyon warning letter & 483s; notice on exosome harms Read More »

Bad Batch podcast’s dark picture of perinatal stem cell industry

John Kosolcharoen, Liveyon

I finished listening to the first 6 episodes of the Bad Batch podcast last week. The series is by medical journalist Laura Beil. I think there will be a 7th episode that’s a Q&A. I highly recommend listening to the series even if parts are wrenching at times like how much patients and families have

Bad Batch podcast’s dark picture of perinatal stem cell industry Read More »

Subscribe to Our Newsletter

Be the first to know about the latest developments in stem cell and regenerative medicine research.